Physician profile

Timothy Canty

Pain Medicine (Anesthesiology) · New York, NY

NPI 1043201452

$14,268.83

in general payments reported to CMS, 2019-2025

43 companies · $811 in 2025

The $811 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).

See the full distribution for Pain Medicine (Anesthesiology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,010.59

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $5,869.08 2019-2025 Wavewriter Alpha Prime 16, Infinion 16, Intracept
Scilex Pharmaceuticals INC. $1,118.88 2019-2025 Ztlido
Spinal Simplicity, LLC $908.40 2022
Nevro Corp. $873.25 2019-2024 Senza
Relievant Medsystems, INC. $780.97 2019-2023 Intracept
Medtronic, INC. $672.07 2021-2025 Inceptiv, Intellis Adaptivestim
Mml US, INC. $492.05 2022
Neuronetics, INC. $360.89 2022
Si-Bone, INC. $355.96 2019-2024
Abbott Laboratories $312.94 2021-2024 Proclaim
Biotronik Nro, INC. $256.11 2025 Prospera
Collegium Pharmaceutical, INC. $249.39 2019-2024 Xtampza
Vertos Medical, INC. $212.66 2020-2024 Mild Device Kit
Medtronic USA, INC. $195.39 2019-2020
Painteq LLC $172.40 2024 Painteq
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Kowa Pharmaceuticals America, INC. $156.99 2022-2023 Seglentis
Curonix LLC $126.30 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Saluda Medical Americas, INC. $116.95 2024 Evoke
Horizon Therapeutics Plc $114.98 2019-2022
Spr Therapeutics, INC $96.61 2019-2025 Sprint Pns System
Abbvie INC. $94.53 2022-2025
Nalu Medical, INC. $94.29 2021-2022
Averitas Pharma INC. $68.42 2024 Qutenza
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $67.87 2019-2025 Relistor
Fujifilm Sonosite, INC. $51.58 2020
Globus Medical, INC. $42.69 2025 Senza
Grt US Holding, INC. $40.26 2021
Daiichi Sankyo INC. $36.80 2019
Shionogi INC $32.76 2019
Virtus Pharmaceuticals LLC $30.51 2021
Depuy Synthes Sales INC. $29.67 2019-2021
Ipsen Biopharmaceuticals, INC $25.34 2025 Dysport
Zyla Life Sciences, INC. $25.04 2019
Zimmer Biomet Holdings, INC. $24.69 2024 Gel-One Cross-Linked Hyaluronate
Astrazeneca Pharmaceuticals LP $23.86 2019
Bioventus LLC $23.11 2022
Mdd US Operations, LLC $21.64 2021
Orthofix Medical, INC. $20.28 2019
Supernus Pharmaceuticals, INC. $17.58 2019
Stimwave Technologies Incorporated $15.18 2019
Allergan, INC. $14.84 2021
Medline Industries LP $12.81 2021
Biodelivery Sciences International, INC. $12.81 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Timothy Canty

$14,268.83

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $811 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).

https://glasscript.com/doctor/319080/timothy-canty

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.